Abstract:The locus coeruleus (LC), the major source of norepinephrine (NE) in the brain, is an early site of pathology in both Alzheimers disease (AD) and Parkinsons disease (PD), and it undergoes catastrophic degeneration later in both disorders. Dysregulation of the LC is thought to contribute to prodromal symptoms of AD and PD such as anxiety and sleep disturbances, while frank LC-NE loss promotes cognitive decline. However, the mechanisms responsible for its selective vulnerability are unknown. The LC is among the only structures in the brain that produces appreciable amounts of neuromelanin (NM), a dark cytoplasmic pigment. It has been proposed that NM initially plays a protective role by sequestering toxic catecholamine metabolites and heavy metals, but may become harmful during aging as it overwhelms cellular machinery and is released during neurodegeneration. Rodents do not naturally produce NM, limiting the study of causal relationships between NM and LC pathology. Adapting a viral-mediated approach for expression of human tyrosinase, the enzyme responsible for peripheral melanin production, we successfully promoted pigmentation in mouse LC neurons that recapitulates key ultrastructural features of endogenous NM found in primates. Pigment expression results in LC neuron hyperactivity, reduced tissue NE levels, transcriptional changes, and novelty-induced anxiety phenotypes as early as 1-week post-injection. By 6-10 weeks, NM accumulation is associated with severe LC neuron neurodegeneration and microglial engulfment of the pigment granules, while the anxiety-like behavior is abated. These phenotypes are reminiscent of LC dysfunction and cell death in AD and PD, validating this model for studying the consequences of pigment accumulation in the LC as it relates to neurodegenerative disease.

Tyrosinase Depletion Prevents the Maturation of Melanosomes in the Mouse Hair Follicle

Establishment of a synchronized tyrosinase transport system revealed a role of Tyrp1 in efficient melanogenesis by promoting tyrosinase targeting to melanosomes

The Influences of Over-Expressing Mir-137 on TYRP-1 and TYRP-2 in Melanocytes

Gene expression profiles of skin from cyclin dependent kinases 5-knockdown mice

CRISPR/Cas9-mediated Mutation of Tyrosinase (tyr) 3′ UTR Induce Graying in Rabbit

Mouse fibroblast expressing human tyrosinase with DHICA-oxidase activity produces predominantly pheomelanin deposit in lysosome

Research Progress on TYR Gene

MITF Is Regulated by Redox Signals Controlled by the Selenoprotein Thioredoxin Reductase 1

Approaches to Identify Inhibitors of Melanin Biosynthesis via the Quality Control of Tyrosinase

Tyrosinase-induced neuromelanin accumulation triggers rapid dysregulation and degeneration of the mouse locus coeruleus

Pigmentation and TYRP1 expression are mediated by zinc through the early secretory pathway-resident ZNT proteins

[The Regulating Effect of Antisense-S-oligo on TYR Gene Expression and Melanin Production of Melanocytes].

MITF-M regulates melanogenesis in mouse melanocytes

Diacylglycerol kinase regulates tyrosinase expression and function in human melanocytes

Protein Biochemistry and Molecular Modeling of the Intra-Melanosomal Domain of Human Recombinant Tyrp2 Protein and OCA8-Related Mutant Variants

mTORC1 activity negatively regulates human hair follicle growth and pigmentation

Tyrosinase Small Interfering RNA Effectively Suppresses Tyrosinase Gene Expression in Vitro and in Vivo

Nuclear Entry of CRTC1 as Druggable Target of Acquired Pigmentary Disorder

UCHL1 Regulates Melanogenesis through Controlling MITF Stability in Human Melanocytes

Influence of depigmenting chemical agents on hair and skin color in yellow (pheomelanic) and black (eumelanic) mice

Melatonin inhibits senescence-associated melanin pigmentation through the p53-TYR pathway in human primary melanocytes and the skin of C57BL/6 J mice after UVB irradiation